[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350120-105":59,"doc-detail-350120-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","harnessing-the-lncrna-ccat2-role-in-gastric-cancer-from-molecular-insights-to-clinical-implications","Harnessing the LncRNA CCAT2 role in gastric cancer - from molecular insights to clinical implications","","Gastric cancer is a major global health problem with high morbidity and mortality, often diagnosed at advanced stages due to limited early clinical manifestations. Risk factors include Helicobacter pylori infection, diet-related exposures, tobacco use, and inherited susceptibility. Diagnosis commonly relies on endoscopy and biopsy, while therapy includes surgery and chemotherapy. Long non-coding RNAs (lncRNAs) are increasingly linked to cancer biology, and CCAT2 shows higher expression in gastric tumors, correlating with poor prognosis, lymph node metastasis, and advanced stage. Functional evidence suggests CCAT2 promotes migration, epithelial-mesenchymal transition (EMT), and invasion via pathways such as PI3K/mTOR, supporting its potential as a diagnostic and prognostic biomarker and a target for new therapeutic strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/harnessing-the-lncrna-ccat2-role-in-gastric-cancer-from-molecular-insights-to-clinical-implications/350120/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/harnessing-the-lncrna-ccat2-role-in-gastric-cancer-from-molecular-insights-to-clinical-implications/350120.png","ImageObject",300,407,{"name":92,"@type":93},"Aria Callaghan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does CCAT2 play in gastric cancer progression?","Question",{"text":112,"@type":113},"CCAT2 is expressed at higher levels in gastric tumor tissues than in normal tissues and is linked to poor prognosis, lymph node metastasis, and advanced tumor stages. Functional studies indicate it promotes cancer cell migration, EMT, and invasion.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What diagnostic or prognostic value does CCAT2 have?",{"text":117,"@type":113},"The review evaluates CCAT2 as a potential diagnostic and prognostic biomarker. Its association with tumor stage and lymph node metastasis supports its relevance for patient outcome prediction.",{"name":119,"@type":110,"acceptedAnswer":120},"Which biological pathways are implicated in CCAT2-related gastric cancer mechanisms?",{"text":121,"@type":113},"CCAT2 is reported to influence cancer cell behaviors through key regulatory pathways, including PI3K/mTOR. These pathways connect CCAT2 activity to migration, EMT, and invasion processes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350120,1791625707,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Behzadnia etal. Cancer Cell International (2026) 26:167 Cancer Cell International  \n[https://doi.org/10.1186/s12935-026-04224-3](https://doi.org/10.1186/s12935-026-04224-3)  \nREVIEW Open Access  \nHarnessing the LncRNA CCAT2 role in gastric  cancer: from molecular insights to clinical implications  \nAmin Behzadnia 1†, Ahmad GhorbaniVanan2†, Kamyar Bagheri3†, Farid Ghorbaninezhad2†, Fatemeh Ghadyani4, Mohammadreza Dashti5, Mahfam Edrisian6, Narges Hedayatian7,8, SafaTahmasebi2* and Elham Safarzadeh9*  \nAbstract  \nCancer is a critical global health issue due to its high morbidity and mortality rate. Gastric cancer is among the five most frequently diagnosed cancers and is the third leading cause of cancer-related death. Risk factors include Helicobacter pylori infection, poor diet, tobacco use, and inherited susceptibility. Diagnosis often involves endoscopy and biopsy, and treatment options include surgery and chemotherapy. Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer biology. Colon cancer-associated transcript 2 (CCAT2) has been identified as a key factor in the development and progression of gastric cancer. CCAT2 is expressed at higher levels in gastric tumor tissues compared with normal tissues and is linked to poor prognosis, lymph node metastasis, and advanced tumor stages. Functional studies suggest that CCAT2 promotes cancer cell migration of cancer cells, epithelial-mesenchymal transition (EMT), and invasion through key regulatory pathways including PI3K/mTOR. This review aims to discuss how lncRNA CCAT2 contributes to gastric cancer growth and to evaluate its potential as both a diagnostic and prognostic biomarker, which may support the development of new therapeutic strategies and improve patient outcomes.  \nKeywords Gastric cancer, LncRNA, CCAT2, Diagnosis, Prognosis, Biomarker  \n†Amin Behzadnia, Ahmad GhorbaniVanan, Kamyar Bagheri and Farid Ghorbaninezhad contributed equally to this work.  \n*Correspondence:  \nSafaTahmasebi[safa.tahmasebi@sbmu.ac.ir](safa.tahmasebi@sbmu.ac.ir)[ ](safa.tahmasebi@sbmu.ac.ir)Elham Safarzadeh [Elham.im63@gmail.com](Elham.im63@gmail.com)  \n1Department of Medical Engineering, South Tehran Branch, Islamic Azad University, Tehran, Iran  \n2Student Research Committee, Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran  \n3Student Research Committee, Abadan University of Medical Sciences, Abadan, Iran  \n4Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran  \n5Student Research Committee, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran  \n6Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran  \n7Department of Genetics, Islamic Azad University Zanjan, Zanjan, Iran 8Nama Gene Azma Co. Health Innovation Center, Tehran, Iran 9Cancer Immunology and Immunotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, Iran  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy ","cbCaiphL8ZjSm8Xv","https://ap.wps.com/l/cbCaiphL8ZjSm8Xv","pdf",1867634,13,"English","# Abstract\n# Introduction\n## Gastric cancer burden and risk factors\n## lncRNAs and CCAT2 in cancer biology","[{\"question\":\"What role does CCAT2 play in gastric cancer progression?\",\"answer\":\"CCAT2 is expressed at higher levels in gastric tumor tissues than in normal tissues and is linked to poor prognosis, lymph node metastasis, and advanced tumor stages. Functional studies indicate it promotes cancer cell migration, EMT, and invasion.\"},{\"question\":\"What diagnostic or prognostic value does CCAT2 have?\",\"answer\":\"The review evaluates CCAT2 as a potential diagnostic and prognostic biomarker. Its association with tumor stage and lymph node metastasis supports its relevance for patient outcome prediction.\"},{\"question\":\"Which biological pathways are implicated in CCAT2-related gastric cancer mechanisms?\",\"answer\":\"CCAT2 is reported to influence cancer cell behaviors through key regulatory pathways, including PI3K/mTOR. These pathways connect CCAT2 activity to migration, EMT, and invasion processes.\"}]","Harnessing the LncRNA CCAT2 role in gastric cancer - from molecular insights to clinical implications | PDF",1790087254,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fe1028760e8e650326733a9b56715c9.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3208b85302716023a13b1562e962a6d9.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c813c377d56f3bc827c3a0cdf57a0038.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d534cf0aa4fdb401633154040730ac8.webp",980,1306]